New research has ingredients for medical 3D printing success

Monday, 16 January 2023

A new research project has been awarded over £6m to develop a toolkit to allow 3D printed medicines to be manufactured effectively bringing innovations like biological personalised pills and ‘living plasters’ closer to commercial production.

The EPSRC funded five-year project is a collaboration being led by researchers from Engineering and Pharmacy at the University of Nottingham, alongside the Universities of Cambridge, Reading and Strathclyde.

The teams will work together develop a toolkit that will allow industry to identify, select and process the correct materials to 3D print into new regenerative medicines and pharmaceuticals.

Professor Ricky Wildman from the University of Nottingham’s Faculty of Engineering is leading the project and explains: “There is currently a lack of agility in UK manufacturing preventing 3D printing being developed in certain areas of industry. Manufacturing needs the capability to quickly, predictably, and reliably 'dial up' performance to produce products embedded with advanced functionality.

“Many pharmaceutical firms don’t know what how to go from concept to reality with 3D printing. They aren’t sure what materials are 3D-printable, or which order to combine the materials or what function different geometric profiles have. This new project aims to provide all of this information to enable commercial application.”

Using computational modelling and machine learning the team will develop instructions for use by industry to accelerate the development cycle of new drugs, which could reduce timescales from two years to six months.

As part of the project three test pharmaceutical products will he developed and tested, all of which rely on the incorporation of proteins or enzymes to promote cell growth and have customisable, complex and multi-material requirements.

The team are testing a biological pill that could potentially replace injected vaccines. The 3D printed personalised pill could be posted to the patient and taken easily, cutting out issues with logistics, delivery and administering of the drug.

An intestinal patch or ‘living plaster’ is also being developed that could calm inflammation potentially helping patients with Crohn’s or bowel disease. The plaster would be laid over the internal area and release active ingredients to help heal and support cell renewal.

Professor Clive Roberts from the University of Nottingham’s School of Life Sciences adds: “Whilst these products are in their infancy we are hoping to be able to develop these innovations to demonstrate the capabilities of the 3D printing tool kit and be able to show how we can combine materials to provide personalised medicines that are safe, effective and low cost.”

"This is very exciting work which, through building cellular models, will improve our understanding of how the gut functions," said Professor Mohammad llyas, a consultant at NHS Nottingham. "More importantly, if successful, it will lead to a paradigm shift in clinical management and launch the use of autologous tissue-engineered therapeutics for the treatment of bowel disease."

Story credits

More information is available from Professor Ricky Wildman on

Jane Icke - Media Relations Manager Science
Phone: 0115 7486462

Notes to editors:

About the University of Nottingham

Ranked 32 in Europe and 16th in the UK by the QS World University Rankings: Europe 2024, the University of Nottingham is a founding member of the Russell Group of research-intensive universities. Studying at the University of Nottingham is a life-changing experience, and we pride ourselves on unlocking the potential of our students. We have a pioneering spirit, expressed in the vision of our founder Sir Jesse Boot, which has seen us lead the way in establishing campuses in China and Malaysia - part of a globally connected network of education, research and industrial engagement.

Nottingham was crowned Sports University of the Year by The Times and Sunday Times Good University Guide 2024 – the third time it has been given the honour since 2018 – and by the Daily Mail University Guide 2024.

The university is among the best universities in the UK for the strength of our research, positioned seventh for research power in the UK according to REF 2021. The birthplace of discoveries such as MRI and ibuprofen, our innovations transform lives and tackle global problems such as sustainable food supplies, ending modern slavery, developing greener transport, and reducing reliance on fossil fuels.

The university is a major employer and industry partner - locally and globally - and our graduates are the second most targeted by the UK's top employers, according to The Graduate Market in 2022 report by High Fliers Research.

We lead the Universities for Nottingham initiative, in partnership with Nottingham Trent University, a pioneering collaboration between the city’s two world-class institutions to improve levels of prosperity, opportunity, sustainability, health and wellbeing for residents in the city and region we are proud to call home.

More news…

Media Relations - External Relations

The University of Nottingham
YANG Fujia Building
Jubilee Campus
Wollaton Road
Nottingham, NG8 1BB

telephone: +44 (0) 115 951 5798